J Korean Soc Ultrasound Med.
2011 Mar;30(1):1-6.
A Glance at the Bethesda System for Reporting Thyroid Cytopathology
- Affiliations
-
- 1Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Korea. ekkim@yuhs.ac
Abstract
- Fine needle aspiration biopsy (FNAB) is an accurate and cost effective diagnostic tool for differentiating malignant and benign thyroid nodules. Despite the efforts of the Papanicolaou group to standardize thyroid cytopathology reporting, no universal standard reporting system exists to date. Pathologists believe that clinicians sufficiently understand FNAB cytological reports. However, this is not necessarily the case. There is often a significant gap between pathologists' beliefs and the clinicians' understanding. As a result, we propose "The Bethesda System for Reporting Thyroid Cytopathology" by the National Cancer Institute. In this editorial, we briefly introduce the Bethesda System for Reporting Thyroid Cytopathology.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Welcoming the new, revisiting the old: a brief glance at cytopathology reporting systems for lung, pancreas, and thyroid
- What’s new in thyroid pathology 2024: updates from the new WHO classification and Bethesda system
- Highlights of the 2023 Bethesda System for Reporting Thyroid Cytopathology, 3rd Edition
- Thyroid Cytology in India: Contemporary Review and Meta-analysis
- Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital
